Associated Papers
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
Liu Y et al.
Bmc Nephrology, 2024
Genetics of Alzheimer's disease: an East Asian perspective.
Miyashita A et al.
Journal of Human Genetics, 2023
Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN et al.
Diagnostic Pathology, 2021
An accessible insight into genetic findings for transplantation recipients with suspected genetic kidney disease.
Wang Z et al.
Npj Genomic Medicine, 2021
34215756 (PubMed )
Supplement: 41525_2021_219_MOESM1_ESM.pdf
Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
Yang M et al.
Molecular Genetics & Genomic Medicine, 2020
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H et al.
Journal of Atherosclerosis and Thrombosis, 2018
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Matsunaga A et al.
Clinical and Experimental Nephrology, 2014
A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.
Kodera H et al.
Case Reports in Nephrology and Dialysis, 0
Select a paper to view details